A real-world study showed that patients who had the classical subtype based on an RNA signature had better survival on ...

The committee recommended Keytruda's subcutaneous form for all indications and as neoadjuvant/adjuvant treatment in PD-L1-positive head and neck cancer.

A team from Shriners Children's and Washington University in St. Louis are investigating a new method for personalizing ...

The firm is betting on pairing KTX-1001 with BMS's mezigdomide and Onyx's Pomalyst in a crowded, competitive field.

In a Phase III trial, patients on the highest dose of Tryngolza had a significant reduction in triglyceride levels compared to those on placebo.

Investigators have used base editing to create a treatment for multisystemic smooth muscle dysfunction syndrome, which has ...

The agency approved the injectable version in all settings for which the intravenous version is approved, including biomarker-defined indications.

The cardiac cell therapy firm will use the funds for its drug development and delivery work, including on the heart failure therapy CardiAMP.

The company has already been testing the autologous cell therapy, LioCyx-M004, in patients with certain liver cancers.

Kwangdong will pay Ocugen up to $7.5 million for rights to sell OCU400 in South Korea, plus further milestone payments and royalties on net sales.

Signals from a Phase Ia trial of LP-184 in solid tumors suggested that patients with DNA damage response gene mutations might respond well to the drug.

The firm's commercialization push is fueled by $35.6 million from a recent Series C financing and a $15.5 million ...